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Abstract 
Purpose: To prepare and characterize alcohol-alkaline modified rice starch (MRS) as a disintegrant for 
tablets. 
Methods: The preparation of MRS was carried out using 3 M NaOH and 40 % ethanol solution. 
Characterization carried out for MRS include morphology, swelling capacity, thermal and pasting 
properties. Direct-compressed tablets (DCT) containing either propranolol hydrochloride (PPNL) or 
hydrochlorothiazide (HCTZ) were evaluated for hardness, friability, disintegration time and drug release. 
Results: The microstructure of MRS was different in shape and dimension from that of rice starch (RS). 
The absence of gelatinization endotherm and FT-IR spectral peak for MRS correlated with change in 
MRS structure and arrangement. MRS showed significantly higher swelling capacity (p < 0.05) than RS, 
and also proved to be a disintegrant in DCT. The disintegration time of the tablets containing MRS was 
lower in the presence of large particles (3.55 ± 0.56 min); high content of MRS  (1.03 ± 0.06 min); low 
content of lubricant (3.16 ± 0.44 min); water soluble filler (1.55 ± 0.16 min for Super-tab®); and model 
drug (0.84 ± 0.09 min for HCTZ)  (p < 0.05).   
Conclusion: MRS exhibits improved water solubility and swelling capacity compared with RS, and is 
thus a good disintegrant for direct-compressed tablet formulations, especially in the presence of water 
insoluble fillers.   
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Fast-release tablet is one of the widely used 
dosage forms for oral administration because of 
convenience and short onset of action, and tablet 
production by direct compression method is very 
popular due to the simplicity, low cost and 
efficiency [1]. Disintegrants are very important 
substance required for the fast-release of active 
constituents from tablet dosage forms because 
they facilitate the rapid breaking of the tablet into 
smaller particles [2]. Several compounds have 
been reported for use as tablet disintegrants 
including starch, cellulose, povidone and their 
derivatives [3]. Starch is a natural polymer which 
is widely employed in pharmaceutical 
formulations before or after physical and/or 
chemical modifications with the aim of improving 
its ability to swell in water, and to confer higher 
hardness and lower friability to the tablets [4-7].  
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Alcoholic-alkaline treatment is a simple and 
inexpensive method of the modification of starch 
that confers better swelling and higher water 
solubility at room temperature [6]. This method 
has been used to modify several starches, such 
as corn starch, waxy corn starch and sago starch 
[6,8,9]. Modify waxy maize starches by the 
method was used as a controlled release matrix 
[10].  This study focuses on rice starch (RS) that 
is safe, inexpensive and an important agricultural 
product of Thailand. RS can be used as 
pharmaceutical excipient, such as tablet filler in 
powder form and tablet binder after 
pregelatinization by heating [10,11]. 
Unfortunately, RS cannot be used as a 
disintegrant in tablet because it cannot swell and 
it is insoluble in water. Thus, the RS modification 
could possibly improve swelling and water 
solubility for use in this purpose. 
 
The aim of this study was to investigate the 
tableting properties of alcoholic-alkaline modified 






Ethanol (95 %) was purchased from the Liquor 
Distillery Organization, Thailand.  Methanol and 
citric acid monohydrate were obtained from 
Prolabo®, EC. Other chemicals and solvents 
including NaOH (RCl Labscan, Thailand), and 
hydrochloric acid (Lab-Scan, Ireland) were of 
analytical grade. Propranolol hydrochloride 
(PPNL, Changzhou Yabang, China), 
hydrochlorothiazide (HCTZ, Suzhou Ausun 
Chemical, China), partially pregelatinized maize 
starch (Starch 1500®, Rama Production, 
Thailand), agglomerated lactose (Super-tab®, 
Meggle, Germany), dibasic calcium phosphate 
(Di-comprez®, Sudeep Pharma, India), rice 
starch (Thai Flour Industry, Thailand), sodium 
starch glycolate (Explotab®, Rama Chem, 
Thailand), colloidal silicon dioxide (Aerosil® 200, 
Evonik Industries AG, Germany) and magnesium 
stearate (Fluka Chemika, Switzerland) were of 
commercial grade. 
 
Preparation of MRS 
 
MRS was prepared by a method of Chen and 
Jane [6]. A 200 g of rice starch were suspended 
in 2000 g of 40 % ethanol solution in a blender 
mixer for 15 min. Subsequently, the mixture was 
vigorously stirred with 800 g of 3 M NaOH 
solution for 90 min.  Thereafter, 95 % ethanol 
(1600 ml) was added to the mixture and stirred 
for 15 min at ambient temperature. The solid 
sediment was allowed to settle and the 
supernatant was decanted. The precipitate was 
collected, re-dispersed in 1200 ml of 40 % 
ethanol solution, and neutralized with 0.5 M citric 
acid in 800 ml of ethanol.  The neutralized starch 
was collected by filtration and washed using 40 
% ethanol and 95 % ethanol, respectively. The 
filtered MRS obtained was dried in a hot air oven 
at 50 ºC for 24 h. It was milled, sieved (Nos. 100, 
140 and 200 meshes), kept in aluminium foil bag, 
and stored in desiccators at ambient 
temperature. 
 




Shape and size of RS and MRS were observed 
using scanning electron microscopy (SEM, 
model JSM-5410LV, JEOL, Japan).  Starch 
sample was mounted onto stub, coated with gold 
using low vacuum sputter coating, and viewed 
using the scanning electron microscope. 
 
Differential scanning calorimetry (DSC) 
 
Thermal properties of RS and MRS were 
analyzed by a differential scanning calorimeter 
(Model DSC 822, Mettler Toledo, Switzerland). 
Starch samples (3 mg) were accurately weighed 
in an aluminum pan, and then 7 µL of purified 
water was added. Subsequently, the samples 
were hermetically sealed and allowed to stand 
for 60 min at room temperature prior to recording 
the thermogram by heating the sample of starch 
at a rate of 10 ºC/min from 30 - 120 ºC, and DSC 
thermograms were recorded.   
 
Fourier transform infrared (FTIR) 
spectroscopy  
 
The spectra of RS and MRS were analyzed by 
FTIR spectrophotometer (Spectrum One, Perkin 
Elmer, U.S.A). The starch samples were ground 
with a mortar and pestle together with dried KBr 
(1:10 w/w), compressed to a disk and analyzed 
between wave numbers of 4000 and 450 cm-1 at 




Starch (0.2 g) was poured into a graduated 
cylinder 10 ml and recorded the volume (V0). Ten 
milliliters of distilled water, 0.1 M HCl or pH 6.8 
phosphate buffer were added. The sample was 
kept at ambient temperature for 24 h and 
recorded for the final volume (V1) of the starch 
gel in the cylinder. Swelling capacity was 
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calculated as a ratio of V1/V0 with three 
replicates. 
 
Effect of formulation factors on tablet 
properties  
 
Disintegrant type, particle size and MRS content, 
lubricant content, filler type and drug type were 
studied. The tablets were prepared by direct 
compression method using hydraulic press with 
10 mm diameter flat face punch at 100 kgf/cm2.  
The tablet samples were evaluated for their 
physical properties such as hardness, friability, 
disintegration time and dissolution time. 
 
To study effect of disintegrant type, MRS, RS 
and sodium starch glycolate (Explotab®) were 
used as disintegrants.  Each tablet contained 350 
mg of Di-Comprez®, 2 % w/w of disintegrant, 1 
% w/w of colloidal silicon dioxide and 2 % w/w of 
magnesium stearate.  The effect of particles size 
of MRS was studied for diameters of < 75, 75 - 
106, 106 - 150 µm with the same amount of Di-
Comprez®, disintegrant, colloidal silicon dioxide 
and magnesium stearate. 
 
Three types of fillers, at 350 mg per tablet, were 
used: Di-Comprez®, Super-tab®, and Starch® 
1500. Each formulation contained 2 % w/w of 
MRS, 1 % w/w of colloidal silicon dioxide and 1% 
w/w of magnesium stearate. 
 
The effect of MRS content was assessed 
concentrations of 2, 4, and 8 % w/w. Each tablet 
contained the same ingredients, viz, 350 mg of 
Di-Comprez®, 1 % w/w of colloidal silicon 
dioxide and 1 % w/w of magnesium stearate. 
 
Three concentrations of magnesium stearate at 
1, 3 and 5 % w/w were used to study the effect of 
lubricant concentration on tablet properties. Each 
tablet contained 350 mg of Di-Comprez®, 2 % 
w/w MRS, and 1 % w/w colloidal silicon dioxide. 
 
To study the effect of drug types, propranolol 
hydrochloride (PPNL) 40 mg or 
hydrochlorothiazide (HCTZ) 50 mg were used. 
Formulation of each tablet contained drug, Di-
Comprez®, 4 % w/w MRS, 1 % w/w colloidal 




Tablet hardness was measured (n = 10) by a 
tablet hardness tester (Model VK 200, Vankel®, 
Benchsarer TM Series, USA).  Tablet friability 
was tested using a friability tester (Model 
Friabilator, Vankel®, USA) based on USP 34/NF 
29 [12]. The disintegration time of tablets was 
evaluated (n = 6) using a disintegration 
apparatus (model QC21, Hanson® Research, 
USA). 
 
Drug dissolution of PPNL and HCTZ tablets were 
assessed (n = 6) using a USP type 2 dissolution 
test apparatus (Hanson Research, Northridge, 
CA, USA). Drug concentration in dissolution 
medium was analyzed spectrophotometrically 
(model UV-1201, Shimadzu, Japan) at 289 and 




Statistical analysis of the data obtained was 
carried out using one-way analysis of variance 
(ANOVA) at 95 % confidence level (p < 0.05).  
Significant differences of mean values were 
determined by Scheffe’s test. The SPSS version 








RS particles had a polygonal shape with 3 - 10 
µm diameter (Figures 1a and 1b), whereas 
morphology of MRS showed irregular particles 
with diameter size about 58 – 156 µm (Figures 
1c and 1d). MRS did not show starch grains and 




The DSC pattern of RS showed the temperature 
of onset, peak and end of gelatinization at 73.22, 
75.45 and 79.70 ºC, respectively, whereas MRS 
did not show gelatinization endotherm in the 
temperature range of 30 – 120 ºC (Figure 2), due 
likely to changes in the internal structure of 




RS and MRS showed similar spectra below 800 
cm-1 (Figure 3), which is the fingerprint region of 
starch. This region exhibited the complex 
vibration mode due to the skeletal mode vibration 
of glucose pyranose ring [13,14]. MRS showed 
an obvious change of the peak in the region of 
950 - 900 cm-1 when compared with RS, 
suggesting an alteration of skeletal mode 
vibration of α-1,4 glycosidic linkage [14]. 
Moreover, MRS and RS gave similar peaks at 
approximately 1020, 1079 and 1155 cm-1, 
corresponding to C-O-H and CH2-O-CH2 bonds 
of glucose structures [13,15,16]. These results 
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suggested that the backbone glucose units of 
starch were not changed after modification. The 
peak of RS at 1370 cm-1 originating from CH2 
bending was shifted to higher wavenumber (1399 
cm-1). This peak represented a modification of 
starch chain. The peak at 1648 cm-1 of RS was 
shifted to a lower wave number (1594 cm-1). This 
was attributed to the water adsorbed in the 
amorphous region of starch granules [13,14], 
leading to a change of crystallinity of RS from 
crystalline to amorphous form after treatment. In 
addition, a shift of the peaks of C-H and O-H 
stretching of RS (2930 and 3393 cm-1, 
respectively) suggested that change of structure 
and hydrogen bonding in RS occurred after 
preparation process [17]. 
 
 
Figure 1: Particle morphology of RS at 2000x magnification (a) 5000x magnification (b); and MRS at 2000x 
magnification (c), 5000x magnification (d) 
 
 
              Figure 2: DSC thermograms of RS and MRS 
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      Figure 3: FTIR spectra of RS and MRS 
 
 




RS did not swell in all media used (Figure 4) 
because the tight packing of amylose and 
amylopectin chain of RS obstruct water 
penetration [19]. On the other hand, MRS 
revealed a pH-independent swelling and the 
swelling capacity of MRS was statistically higher 
(p < 0.05) than that of RS, whereas Explotab® 
showed better swelling than MRS in water and 
phosphate buffer system but less in acid 
medium. These findings suggested that MRS 
had strong potential for use as a disintegrant in 
tablets. 
Characteristics of tablets containing MRS 
 
MRS was used as a tablet disintegrant and 
compared with RS and Explotab® (Table 1). The 
hardness of tablet was not significantly different 
(p > 0.05). The friability of tablet without 
disintegrant was lower than those of tablets with 
disintegrant. The tablets containing MRS gave 
statistically shorter disintegration time (p < 0.05) 
than those containing RS, but the use of 
Explotab® resulted in a very short disintegration 
time. 
 
Boonwatcharapan et al 
Trop J Pharm Res, February 2016; 15(2): 226  
 
Table 1: Effect of various ingredients on physical properties of tablets using MRS as a disintegrant 
 
Tablet ingredient Hardness (kp) Friability (%) Disintegration time (min) 
Disintegrant    
None 4.16 ± 0.25 2.27 > 180 
RS 4.26 ± 0.27 2.36 26.03 ± 4.99 
MRS 4.32 ± 0.23 2.61 3.75 ± 0.41 
Explotab 4.02 ± 0.18 2.70 0.84 ± 0.09 
MRS particle size    
< 75 m 4.36 ± 0.17 2.25 4.67 ± 0.68 
75-106 m 4.32 ± 0.23 2.61 3.75 ± 0.41 
106-150 m 4.06 ± 0.19 2.81 3.55 ± 0.56 
MRS content (%)    
2 3.90 ± 0.12 2.98 3.16 ± 0.44 
4 4.18 ± 0.30 2.29 1.42 ± 0.23 
8 4.30 ± 0.23 2.34 1.03 ± 0.06 
Filler type    
Di-comprez 3.90 ± 0.12 2.98 3.16 ± 0.44 
Strach 1500 8.80 ± 0.50 0.40 16.32 ± 2.36 
Super-tab 6.02 ± 0.36 1.92 1.55 ± 0.16 
Lubricant content (%)    
1 3.90 ± 0.12 2.98 3.16 ± 0.44 
3 4.22 ± 0.16 3.07 8.09 ± 1.65 
5 4.82 ± 0.24 2.38 31.68 ± 1.72 
Drug type    
PPNL 4.00 ± 0.14 2.36 2.23 ± 0.16 
HCTZ 3.82 ± 0.11 2.47 0.82 ± 0.12 
 
Particles size of MRS influenced physical 
properties of tablets. Increase of MRS particles 
size caused lower hardness, higher friability and 
shorter disintegration time (Table 1, rows 7 - 10). 
Effect of MRS content on tablets was also 
investigated (Table 1). Increasing MRS content 
resulted in increased hardness of tablet while 
disintegration time was decreased. 
 
MRS was used as a disintegrant of tablets 
prepared using different fillers (Table 1, rows 15 - 
18). Starch 1500® and Super-tab® provided 
higher hardness tablets than Di-comprez®. The 
friability of Di-comprez® was the highest. Tablet 
containing Di-comprez® was lower disintegration 
time than tablet containing Starch 1500® over 5 
times. Thus, filler type affected properties of 
tablets, especially disintegration time. Moreover, 
magnesium stearate, which used as lubricant, 
also affected properties of tablets containing 
MRS. Hardness and disintegration time were 
significantly increased (p < 0.05) with increasing 
magnesium stearate content (Table 1, row 19-
22), whereas friability of tablets tended to 
decrease with higher magnesium stearate 
content. 
 
The properties of tablets containing PPNL and 
HCTZ, high and low water solubility drugs, 
respectively, were studied (Table 1). Hardness 
and friability of PPNL and HCTZ tablets were not 
significantly different (p > 0.05). Disintegration 
time of HCTZ was significantly lower (p < 0.05) 
than PPNL. Moreover, dissolution profile of both 
tablets is shown in Figure 5. T50%, i.e. the time to 
achieve 50 % drug dissolved, of PPNL and 
HCTZ tablets was 2.54 ± 0.17 and 11.15 ± 1.15 
min, respectively, due probably to the difference 




The morphology and particles size of RS 
obtained were similar to that reported by other 
researchers [18,19]. However, MRS did not 
appear as granules likely because they were 
swollen and ruptured during modification process 
[6,8,20]. The complex structure of RS consists of 
long chain amylose linked with branch chain 
amylopectin. The proton of OH group may 
dissociate leaving negative charges on the starch 
molecules after treatment with strong base 
(NaOH). The repulsion between negative 
charges leads to swelling after water absorption. 
Then, dissociation of double-helix regions of 
starches lead to breakdown and change of 
crystalline structure, and the distortion of starch 
morphology [8,9]. This structural change 
following alcoholic-alkaline treatment, causing 
the disappearance of gelatinization endotherm 
[8,9,19], was confirmed by FT-IR analysis of 
position and intensity of infrared band for RS and 
MRS [21,22]. The intensity of α-1,6 glycosidic 
linkage of the amylopectin (CH2 bonding around 
1399 cm-1, and OH stretching around 3417 cm-1) 
of MRS was lower than RS. 
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Figure 5: Dissolution profiles of PPNL and HCTZ tablets containing 4 % w/w MRS as a disintegrant 
 
Moreover, the amorphous region of starch where 
water molecules could be tightly adsorbed 
(around 1594 cm-1) showed a low absorption, 
resulting in decreased crystallinity degree of 
MRS. The molecule of water can interact easier 
with MRS, resulting in viscosity, swelling and 
solubility improvement with respect to RS [8]. 
Consequently, MRS provided better pH-
independent swelling capacity than RS.   
 
MRS was used as a tablet disintegrant in 
comparison with RS and Explotab®, a low 
substituted carboxy methyl starch 
(superdisintegrants). MRS showed shorter 
disintegration time than RS because of higher 
swelling capacity. Polymer swelling is one of the 
mechanisms of tablet disintegration; rapid water 
absorption and swelling of disintegrant caused a 
break of tablet to smaller particles for enhancing 
drug dissolution [23]. However, MRS gave longer 
disintegration time than Explotab®, because of 
lower swelling capacity of MRS. For particles 
size of MRS, tablet containing smaller particles of 
MRS had the highest hardness and the lowest 
friability because of tightly packing with other 
ingredients in the tablet. The closed packing of 
particles caused a retardation of water 
absorption and swelling of MRS, resulting in 
longer disintegration time of tablets.  
 
Furthermore, tablet properties were strongly 
influenced by MRS content. Increase of MRS 
gave greater hardness and lower friability of the 
tablets, exhibiting important benefits over native 
RS. Moreover, higher disintegrant content allows 
a rapid uptake of water followed by fast and 
significantly higher swelling, leading to tablets 
break up in shorter time. In particular, the highest 
content (8 %) of MRS showed the best 
disintegration action in this study.  
 
Tablet properties were dependent upon the filler 
added. Various types of fillers, such as Di-
comprez®, Starch 1500® and Super-Tab®, were 
used in this study. The tablets containing Super-
tab®, lactose anhydrous, had lower 
disintegration time than those containing Di-
comprez®, dibasic calcium phosphate, because 
water absorption may occur rapidly in tablets 
prepared using hydrophilic fillers. However, the 
highest disintegration time was found in the 
tablets containing Starch1500®. Starch1500® is 
a partially pregelatinized maize starch that can 
be partially swollen in water. The swelling of 
Starch1500® may retard water absorption and 
then reduce the MRS efficiency for tablet 
disintegrant. Moreover, the greatest tablet 
hardness of the tablet containing Starch1500® 
may also affect the disintegration time. 
 
Lubricant effect is essential in developing a 
suitable excipient for tablets. In this study, 
increase in magnesium stearate content provided 
higher hardness, but lower friability of tablets was 
obtained. The disintegration time of the tablets 
significantly increased with increasing 
magnesium stearate content. These results 
indicate that the hydrophobicity of magnesium 
Boonwatcharapan et al 
Trop J Pharm Res, February 2016; 15(2): 228  
 
stearate retarded the absorption of water and 
polymer swelling which strongly influenced 
disintegration time, and this is in agreement with 
the findings of Wang et al [24]. 
 
MRS was used as a disintegrant in PPNL and 
HCTZ tablets. The results showed that MRS 
gave high disintegration efficiency in both tablets, 
and the disintegration time was in the range of 
0.82 - 2.23 min. HCTZ tablets showed faster 
disintegration time than PPNL tablets. Tablet 
disintegration normally promotes drug 
dissolution. However, HCTZ tablets showed 
slower dissolution rate than PPNL due probably 




Alcoholic-alkaline treatment changes the 
structure and properties of RS. The disruption of 
molecular bonding within the crystalline structure 
of starch confers enhanced characteristics on 
MRS, relative to native RS, including higher 
water solubility and swelling behavior, and faster 
disintegration. Consequently, MRS has a strong 
potential for use as an effective disintegrant in 
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